347 related articles for article (PubMed ID: 18327393)
1. P2 receptors, platelet function and pharmacological implications.
Gachet C
Thromb Haemost; 2008 Mar; 99(3):466-72. PubMed ID: 18327393
[TBL] [Abstract][Full Text] [Related]
2. The platelet P2 receptors in thrombosis.
Gachet C; Hechler B
Semin Thromb Hemost; 2005 Apr; 31(2):162-7. PubMed ID: 15852219
[TBL] [Abstract][Full Text] [Related]
3. Regulation of platelet functions by P2 receptors.
Gachet C
Annu Rev Pharmacol Toxicol; 2006; 46():277-300. PubMed ID: 16402906
[TBL] [Abstract][Full Text] [Related]
4. The P2 receptors in platelet function.
Hechler B; Cattaneo M; Gachet C
Semin Thromb Hemost; 2005 Apr; 31(2):150-61. PubMed ID: 15852218
[TBL] [Abstract][Full Text] [Related]
5. P2Y12 receptor in platelet activation.
Kim S; Kunapuli SP
Platelets; 2011; 22(1):56-60. PubMed ID: 21231822
[TBL] [Abstract][Full Text] [Related]
6. The platelet P2 receptors as molecular targets for old and new antiplatelet drugs.
Gachet C
Pharmacol Ther; 2005 Nov; 108(2):180-92. PubMed ID: 15955565
[TBL] [Abstract][Full Text] [Related]
7. ADP receptors of platelets and their inhibition.
Gachet C
Thromb Haemost; 2001 Jul; 86(1):222-32. PubMed ID: 11487010
[TBL] [Abstract][Full Text] [Related]
8. Platelet P2 receptors: old and new targets for antithrombotic drugs.
Cattaneo M
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):45-55. PubMed ID: 17187456
[TBL] [Abstract][Full Text] [Related]
9. ADP receptors: inhibitory strategies for antiplatelet therapy.
Cattaneo M
Drug News Perspect; 2006 Jun; 19(5):253-9. PubMed ID: 16941047
[TBL] [Abstract][Full Text] [Related]
10. Clopidogrel versus prasugrel in rabbits. Effects on thrombosis, haemostasis, platelet function and response variability.
Wong PC; Crain EJ; Watson CA; Hua J; Schumacher WA; Rehfuss R
Thromb Haemost; 2009 Jan; 101(1):108-15. PubMed ID: 19132196
[TBL] [Abstract][Full Text] [Related]
11. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
[TBL] [Abstract][Full Text] [Related]
12. Adenosine diphosphate receptors on blood platelets: potential new targets for antiplatelet therapy.
Rozalski M; Nocun M; Watala C
Acta Biochim Pol; 2005; 52(2):411-5. PubMed ID: 15912207
[TBL] [Abstract][Full Text] [Related]
13. P2Y receptor antagonists in thrombosis.
Boeynaems JM; van Giezen H; Savi P; Herbert JM
Curr Opin Investig Drugs; 2005 Mar; 6(3):275-82. PubMed ID: 15816504
[TBL] [Abstract][Full Text] [Related]
14. The P2Y12 receptor as a therapeutic target in cardiovascular disease.
Storey RF
Platelets; 2001 Jun; 12(4):197-209. PubMed ID: 11454254
[TBL] [Abstract][Full Text] [Related]
15. Preclinical and clinical studies with selective reversible direct P2Y12 antagonists.
van Giezen JJ; Humphries RG
Semin Thromb Hemost; 2005 Apr; 31(2):195-204. PubMed ID: 15852223
[TBL] [Abstract][Full Text] [Related]
16. Platelet aggregation and adenosine diphosphate/adenosine triphosphate receptors: a historical perspective.
Packham MA; Mustard JF
Semin Thromb Hemost; 2005 Apr; 31(2):129-38. PubMed ID: 15852216
[TBL] [Abstract][Full Text] [Related]
17. The platelet P2 receptors in arterial thrombosis.
Gachet C; Léon C; Hechler B
Blood Cells Mol Dis; 2006; 36(2):223-7. PubMed ID: 16466948
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
von Kügelgen I
Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
[TBL] [Abstract][Full Text] [Related]
19. Platelet activation by ADP: the role of ADP antagonists.
Gachet C
Ann Med; 2000 Dec; 32 Suppl 1():15-20. PubMed ID: 11209975
[TBL] [Abstract][Full Text] [Related]
20. The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets.
Bambace NM; Levis JE; Holmes CE
Platelets; 2010; 21(2):85-93. PubMed ID: 20063989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
